The MPDD has 510k FDA approval. The inventor is a world renowned pain managment Dr from NYC. The device has an 82 pct sucess rate in studies at NYU. 10 millions dollars in debt has been converted in equity by the debt holders,which leaves EPGL with no debt. The O/S will be approx 499 million after the r/s. The restructure of the company is being done by Pwc which is a top rated and one of the largest accountanting firms in the world. The sciencetist who hold the patent for the device along with Dr Marcus have very impressive backgrounds in the Medical device field. These are just a few reasons why alot of people think this is gonna run.